Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate

Clinical Cancer Research

Volumn 3, Issue 2, 1997, Pages 249-256

  Melchior, Sebastian W ^a,b   Corey, Eva ^a   Ellis, William J ^a   Ross, Amy A ^c   Layton, Tamara J ^c   Oswin, Matthew M ^a   Lange, Paul H ^a   Vessella, Robert L ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Cell Pro Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISSEMINATED CANCER; EARLY CANCER; EARLY DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CARCINOMA;

ADULT; AGED; BIOPSY; BONE MARROW; CELL COUNT; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

EID: 0031037160     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Wingo, P. A., Tong, T., and Bolden, S. Cancer statistics, 1995. CA Cancer J. Clin., 45: 8-30, 1995.
2. Epstein, J. I., Carmichael, M. J., Pizov, G., and Walsh, P. C. Influence of capsular penetration on progression following RP: a study of 196 cases with long-term follow-up. J. Urol., 150: 135-141, 1993.
3. Cote, R. J., Rosen, P. P., and Lesser, N. L. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J. Clin. Oncol., 9: 1749-1756, 1991.
4. Moss, T. J., and Sanders, D. G. Detection of neuroblastoma cells in blood. J. Clin. Oncol., 5: 736-740, 1990.
5. Bretton, P. R., Melamed, M. R., Fair, W. R., and Cote, R. J. Detection of occult micrometastases in the bone marrow of patients with prostate carcinoma. Prostate, 25: 108-114, 1994.
6. Oberneder, R., Riesenberg, R., Kriegmair, M., Bitzer, U., Klammert, R., Schneede, P., Hofstetter, A., Riethmueller, G., and Pantel, K. Immunocytochemical detection and phenotypic characterization of micro-metastatic tumor cells in bone marrow of patients with prostate cancer. Urol. Res., 22: 3-8, 1994.
7. Katz, A. E., DeVries, G. M., Begg, M. D., Raffo, A. J., Cama, C., O'Toole, K., Buttyan, R., Benson, M. C., and Olsson, C. A. Enhanced reverse transcriptase polymerase chain reaction for prostate-specific antigen as an indicator of true pathological stage in patients with prostate cancer. Cancer (Phila.), 75: 1642-1647, 1995.
8. Olsson, C. A., DeVries, G. M., Raffo, A. J., Benson, M. C., O'Toole, K., and Cao, Y. Preoperative reverse transcriptase polymerase chain reaction for prostate-specific antigen predicts treatment failure following RP. J. Urol., 155: 1557-1562, 1996.
9. Wood, D. P., Banks, E. R., Humphreys, S., McRoberts, J. W., and Rangnekar, V. M. Identification of bone marrow micrometastases in patients with prostate cancer. Cancer (Phila.), 74: 2533-2540, 1994.
10. Hermanek, P., and Sobin, L. H. (eds.). UICC TNM Classification of Malignant Tumors, 4th ed., 2nd rev. Berlin: Springer-Verlag, 1992.
11. Gleason, D. F., Mellinger, G. T., and the Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic carcinoma by combined histological grading and histological staging. J. Urol., 11: 58-64, 1974.
12. Corey, E., Arfman, E. A., Liu, A. Y., and Vessella, R. L. Improved protocol for reverse-transcriptase polymerase chain reaction with exogenous internal competitive control: detection of prostate cancer cells in blood and bone marrow using prostate specific antigen mRNA. Clin. Chem., in press, 1997.
13. Rundles, R. W., and Jonsson, U. Metastases in bone marrow and myelophthistic anemia from carcinoma of the prostate. Am. J. Med. Sci., 218: 242-250, 1949.
14. Clifton, J. A., Phillip, R. J., Fowler, W. M. Bone marrow and carcinoma of the prostate. Am. J. Med. Sci., 224: 121-130, 1952.
15. Mehan, D. J., Brown, G. O., Hoover, B., and Storey, G. Bone marrow findings in carcinoma of the prostate. J. Urol., 95: 241-244, 1966.
16. Riesenberg, R., Oberneder, R., Kriegmair, M., Epp, M., Bitzer, U., Hofstetter, A., Braun, S., Riethmueller, G., and Pantel, K. Immunocytochemical double staining of cytokeratin and prostate-specific antigen in individual prostatic tumor cells. Histochemistry, 99: 61-66, 1993.
17. Nelson, C. M. K., Boatman, D. L., and Flocks, R. H. Bone marrow examination in carcinoma of the prostate. J. Urol., 109: 667-670, 1973.
18. Wood, D. P., Banks, E. R., Humphreys, S., and Rangnekar, V. M. Sensitivity of immunohistochemistry and polymerase chain reaction in detecting prostate cancer cells in bone marrow. J. Histochem. Cytochem., 42: 505-511, 1994.
19. Wood, D. P., Weinstein, M., Humphries, S., and Rangnekar, V. M. Prognostic significance of circulating prostate cells. J. Urol., 155 (Suppl.): 429A, 1996.
20. Miyajima, Y., Kato, K., Numata, S., Kudo, K., and Horibe, K. Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA. Cancer (Phila.), 75: 2757-2761, 1995.
21. Moss, T. J., Sanders, D. G., Lasky, L. C., and Bostrom, B. Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood, 76: 1879-1883, 1990.
22. Ross, A. A., Cooper, B. W., Lazarus, H. M., Mackay, W., Moss, T. J., Ciobanu, N., Tallman, M. S., Kennedy, M. J., Davidson, N. E., Sweet, D., Winter, C., Akard, L., Jansen, J., Copelan, E., Meagher, R. C., Herzig, R. H., Klumpp, T. R., Kahn, D. G., and Warner, N. E. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood, 82: 2605-2610, 1993.
23. Brugger, W., Bross, K. J., Glatt, M., Weber, F., Mertelsmann, R., and Kanz, L. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood, 83: 636-640, 1993.
24. Shpall, E. J., and Jones, R. B. Release of tumor cells from bone marrow. Blood, 83: 623-625, 1993.
25. Ellis, W. J., and Lange, P. H. Managing patients with pathologic C disease and elevated PSA levels after radical prostatectomy. Probl. Urol., 7: 191-204, 1993.
26. Stein, A., deKernion, J. B., Smith, R. B., Dorey, F., and Patel, H. Prostate-specific antigen levels after radical prostatectomy in patients with organ-confined and locally extensive prostate cancer. J. Urol., 147: 192-197, 1992.
27. Smith, R. C., Partin, A. W., Epstein, J. I., and Brendler, C. B. Extended follow-up of the influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer and extensive capsular penetration. J. Urol., 156: 454-458, 1996.
28. Paulson, D. F., Moul, J. W., and Walther, P. J. Radical prostatectomy for clinical stage T1-2N0M0 prostate adenocarcinoma: long-term results. J. Urol., 144: 1180-1184, 1990.
29. Lang, S. H., Allen, T. D., Testa, N. G., George, N. J. R., and Clarke, N. W. Interaction of benign and malignant prostatic epithelia with bone marrow and prostatic stroma. J. Urol., 155 (Suppl.): 1256A, 1996.
30. Moreno, J. G., Long, J. P., O'Hara, M., Veltri, R. W., Alexander, A., Schupp-Byrne, D., and Gomella, L. G. Surgical prostatic instrumentation causes showering of prostate cells into the circulation as determined by RT-PCR of PSA. J. Urol., 155 (Suppl.): 970A, 1996.
31. Cama, C. L., Olsson, C. A., Buttyan, R., Wise, G. J., DeVries, G., and Katz, A. E. Molecular staging of prostate cancer III: effects of digital rectal examination, cystoscopy, and needle biopsy on the enhanced reverse transcriptase polymerase chain reaction assay. J. Urol., 755 (Suppl.): 971A, 1996.
32. Mansi, J. L., Berger, U., Wilson, P., Shearer, R., and Coombes, R. C. Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques. J. Urol., 139: 545-548, 1988.